These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5883214)

  • 41. Irreversible enzyme inhibitors. CLXXIV. Metabolism of 4-(p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)hydrocinnamido)-o-toluenesulfonyl fluoride (NSC-113423), an active-site-directed irreversible inhibitor of dihydrofolic reductase.
    Ryan AJ; Vermeulen NM; Baker BR
    J Med Chem; 1970 Nov; 13(6):1140-2. PubMed ID: 5479853
    [No Abstract]   [Full Text] [Related]  

  • 42. Irreversible enzyme inhibitors. LXXI. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. V. Derivatives of 6-phenylpyrimidine.
    Baker BR; Shapiro HS
    J Pharm Sci; 1967 Jan; 56(1):33-8. PubMed ID: 6030490
    [No Abstract]   [Full Text] [Related]  

  • 43. Irreversible enzyme inhibitors. 88. Differential irreversible inhibition of dihydrofolic reductase from different species.
    Baker BR; Jordaan JH
    J Pharm Sci; 1967 May; 56(5):660-1. PubMed ID: 5340324
    [No Abstract]   [Full Text] [Related]  

  • 44. Irreversible enzyme inhibitors. 168. Irreversible inhibition of dihydrofolate reductase and cell wall transport by pyrimidines and dihydro-s-triazines with pyridinium side chains.
    Baker BR; Vermeulen NM; Ryan AJ
    J Med Chem; 1970 Mar; 13(2):280-4. PubMed ID: 5418502
    [No Abstract]   [Full Text] [Related]  

  • 45. KINETICS AND MECHANISM OF ISOMERIZATION AND HYDROLYSIS OF 4,6-DIAMINO-1-(3,5)-DICHLOROPHENYL-1,2-DIHYDRO-2,2-DIMETHYL-1,3,5-TRIAZINE IN DILUTE AQUEOUS SOLUTION.
    SZULCZEWSKI DH; SHEARER CM; AGUIAR AJ
    J Pharm Sci; 1964 Oct; 53():1156-60. PubMed ID: 14249427
    [No Abstract]   [Full Text] [Related]  

  • 46. ANALOGS OF TETRAHYDROFOLIC ACID. XI. SYNTHESIS AND ENZYMIC EVALUATION OF P-((N-(2-AMINO-4-HYDROXY-6-METHYL-5-PYRIMIDYL)CARBAMOYLMETHYL)AMINO)BENZOYL-L-GLUTAMIC ACID.
    BAKER BR; SACHDEV K
    J Pharm Sci; 1964 Sep; 53():1020-3. PubMed ID: 14234885
    [No Abstract]   [Full Text] [Related]  

  • 47. Computer graphic modeling in drug design--conformational analysis of antifolate binding to avian dihydrofolate reductase: crystal and molecular structures of 2,4-diamino-5-cyclohexyl-6-methylpyrimidine and 5-cyclohexyl-6-methyluracil.
    Cody V; Ciszak E
    Anticancer Drug Des; 1991 May; 6(2):83-93. PubMed ID: 2039584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
    Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Separation of folic acid reductase from Streptococcus faecium (ATCC 8043).
    Speck EL; Affronti LF
    J Bacteriol; 1969 Mar; 97(3):1160-4. PubMed ID: 5776522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 10-Formyl-dihydrofolic acid is bioactive in human leukemia cells.
    Baggott JE; Johanning GL
    J Nutr; 1999 Jul; 129(7):1315-8. PubMed ID: 10395592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative structure-activity relationships of the inhibition of Pneumocystis carinii dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(X-phenyl)-s-triazines.
    Marlowe CK; Selassie CD; Santi DV
    J Med Chem; 1995 Mar; 38(6):967-72. PubMed ID: 7699713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetic studies of the reaction mechanism of dihydrofolate reductase.
    Blakley RL; Schrock M; Sommer K; Nixon PF
    Ann N Y Acad Sci; 1971 Nov; 186():119-30. PubMed ID: 4399848
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on dihydrofolic reductase, II. The activation of dihydrofolic reductase from chicken liver by iodine.
    Kaufman BT
    Proc Natl Acad Sci U S A; 1966 Aug; 56(2):695-700. PubMed ID: 4381832
    [No Abstract]   [Full Text] [Related]  

  • 54. Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity.
    Baker BR; Lourens GJ
    J Med Chem; 1969 Jan; 12(1):92-4. PubMed ID: 5763049
    [No Abstract]   [Full Text] [Related]  

  • 55. ANALOGS OF TETRAHYDROFOLIC ACID. 8. SYNTHESIS OF N-(1-(2-AMINO-4-MERCAPTO-6-METHYL-5-PYRIMIDYL)-3-PROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID, A MERCAPTO ANALOG.
    BAKER BR; MORREAL CE; HO BT
    J Med Chem; 1963 Nov; 6():658-64. PubMed ID: 14184921
    [No Abstract]   [Full Text] [Related]  

  • 56. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ANALOGS OF TETRAHYDROFOLIC ACID. IX. SYNTHESIS OF N-(1-(2-AMINO-4-HYDROXY-6-PHENYL-5-PYRIMIDYL)-3-PROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID, A "NONCLASSICAL" INHIBITOR OF SOME FOLIC COFACTOR AREA ENZYMES.
    BAKER BR; SHAPIRO HS
    J Med Chem; 1963 Nov; 6():664-9. PubMed ID: 14184922
    [No Abstract]   [Full Text] [Related]  

  • 58. Irreversible enzyme inhibitors. CXVII. Hydrophobic bonding to dihydrofolic reductase. XI. Comparison of the enzyme from Walker 256, rat liver, and L1210 mouse leukemia.
    Baker BR
    J Med Chem; 1968 May; 11(3):483-6. PubMed ID: 5241406
    [No Abstract]   [Full Text] [Related]  

  • 59. ANALOGS OF TETRAHYDROFOLIC ACID. X. SYNTHETIC AND ENZYMIC STUDIES ON THE CONTRIBUTION OF THE P-AMINOBENZOYL-L-GLUTAMATE MOIETY OF PYRIMIDYL ANALOGS TO BINDING TO SOME FOLIC COFACTOR AREA ENZYMES.
    BAKER BR; SANTI DV; ALMAULA PI; WERKEISER WC
    J Med Chem; 1964 Jan; 7():24-30. PubMed ID: 14186020
    [No Abstract]   [Full Text] [Related]  

  • 60. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
    Gangjee A; Adair O; Queener SF
    J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.